In the video below, Dr. Whitney addresses common misconceptions about the efficacy of fresh versus frozen stem cells in regenerative medicine.
Drawing from a comprehensive preclinical systematic review encompassing hundreds of studies, he reveals that 98% of in vivo research utilizes frozen stem cells, challenging the notion that fresh cells are inherently superior.
Dr. Whitney emphasizes that the viability and therapeutic potential of stem cells are not compromised by freezing, provided proper protocols are followed.
This evidence-based discussion aims to inform both medical professionals and patients, encouraging decisions rooted in scientific data rather than prevailing myths.
For a deeper understanding of this topic, watch the full video here:
